Absolute assignment of breast cancer intrinsic molecular subtype.
暂无分享,去创建一个
[1] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[2] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[3] T. Lash,et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index , 2009, Breast Cancer Research.
[4] R. Gelber,et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] Jorge S Reis-Filho,et al. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade , 2010, The Journal of pathology.
[6] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[7] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[8] L. Bernstein,et al. Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[10] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Gianluca Bontempi,et al. Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes , 2008, Clinical Cancer Research.
[12] Anton Belousov,et al. Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study , 2014, Clinical Cancer Research.
[13] M. Hallett,et al. The prognostic ease and difficulty of invasive breast carcinoma. , 2014, Cell reports.
[14] Jack Cuzick,et al. Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Theodore R Holford,et al. Molecular and Cellular Pathobiology Transcriptional Profiling Analyses , 2022 .
[16] Xuesong Lu,et al. Predicting features of breast cancer with gene expression patterns , 2008, Breast Cancer Research and Treatment.
[17] Sandrine Dudoit,et al. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments , 2010, BMC Bioinformatics.
[18] L. Holmberg,et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts , 2005, Breast Cancer Research.
[19] Charles M Perou,et al. Clinical implementation of the intrinsic subtypes of breast cancer. , 2010, The Lancet. Oncology.
[20] Simen Myhre,et al. The importance of gene-centring microarray data. , 2010, The Lancet. Oncology.
[21] Z. Wen,et al. Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map , 2011, PloS one.
[22] Zoltan Szallasi,et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer , 2010, Nature Medicine.
[23] Daniel Q. Naiman,et al. Simple decision rules for classifying human cancers from gene expression profiles , 2005, Bioinform..
[24] M. Ringnér,et al. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics , 2010, Breast Cancer Research.
[25] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[28] John Quackenbush,et al. A three-gene model to robustly identify breast cancer molecular subtypes. , 2012, Journal of the National Cancer Institute.
[29] N. Harbeck,et al. Molecular and protein markers for clinical decision making in breast cancer: today and tomorrow. , 2014, Cancer treatment reviews.
[30] Zhiyuan Hu,et al. Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples , 2011, BMC Medical Genomics.
[31] Gordon K. Smyth,et al. A comparison of background correction methods for two-colour microarrays , 2007, Bioinform..
[32] C. Sotiriou,et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures , 2007, Breast Cancer Research.
[33] X. Chen,et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.
[34] A. Ashworth,et al. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. , 2010, The Lancet. Oncology.
[35] Lorenzo Ferraro,et al. Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. , 2010, The American journal of pathology.
[36] J. Stec,et al. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] J. Bergh,et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] F. Bertucci,et al. A refined molecular taxonomy of breast cancer , 2011, Oncogene.
[39] Federico Ambrogi,et al. Challenges in projecting clustering results across gene expression-profiling datasets. , 2007, Journal of the National Cancer Institute.